OTC Markets Stock News
All posts tagged "Breakthrough Therapy Designation"
-
2.0K1BiotechPicking a Bottom in CytoDyn – Right Now
CytoDyn Inc (OTCMKT: CYDY) has been under considerable selling pressure since April and nothing seems to be able to stop it. In...
-
2.7K2BiotechCytoDyn’s Preliminary Phase 1b/2 Cancer Results Likely to Receive Breakthrough Therapy Designation (BTD)
CytoDyn Inc. (OTCMKTS: CYDY) announced excellent preliminary results from its Phase 1b/2 clinical trial in metastatic triple negative breast cancer...
-
16.6K6BiotechLeronlimab Trial Results All But Certain Pointing to Approval For CytoDyn
CytoDyn Inc. (OTMKTS: CYDY) announced discussions with 3 regulatory agencies after an unblinding of the data on February 22, 2021, and the...
-
14.1K1BiotechCytoDyn (OTCMKTS: CYDY) Bolts Higher On Mexican Approval Chatter
Yesterday CytoDyn Inc. (OTCMKTS: CYDY) moved up 27% on the completion of a Memorandum of Understanding with the NIH of Mexico to...
-
22.5KBiotechInvestors Fleeing CytoDyn Missing the Golden Nugget from the BLA Delay
Sell first analyze later mentality of investors oblivious to the increased likelihood of a BLA approval may cost them handsome upside CytoDyn...